“…As regards the choice of substitutes, a heart valve allograft is considered superior to the other prosthesis like mechanical valves and bioprosthetic valves. Since the 1990s, several retrospective studies have shown that possible superiority of the valve allograft use for severe infective endocarditis and prosthetic valve endocarditis cases from the clinical results [Grinda et al, 2005;Haydock et al, 1992;Leyh et al, 2004;Sabik et al, 2002;Vogt et al, 1997;Yankah et al, 2005] ; however, there is no final consensus of an allografts' potential of antimicrobial capacity due to the absence of randomized controlled studies and scientific evidence supporting this mechanism [Eichinger et al, 2002;Rowe et al, 1999], and the presence of opposing opinions [El-Hamamsy et al, 2010;Klieverik et al, 2009]. Further information was contributed in 2008 by our group to strongly support the allografts' property to overcome infection from a scientific point of view; the key substance conferring the antibacterial property was found to be indoleamine 2,3-dioxygenase (IDO) [Narui et al, 2009;Saito et al, 2008].…”